Author: super@dmin
-

Key Words: Citigroup CEO makes 486 times more than the bank’s rank-and-file, and he says his story should be aspirational
Michael Corbat earned $24.1 million last year as the boss at Citigroup, while the median pay for the rest of the workforce is less than $50,000. Does he feel there’s a problem that needs addressing?
-

Are two mutual funds enough?
How to get better returns with less drama
-

The stock market’s reaction to this one word from the Fed’s Powell shows investors should be careful
Investors are hoping for continued low interest rates, but they may not get their wish.
-

This may be why Americans are so bad at saving for retirement
There isn’t enough data on retirement — and where you fit in
-

Metals Stocks: Gold touches more than 4-month low as rate-cut bets cooled by Fed statements
Gold futures head sharply lower Thursday, putting bullion on pace for the lowest settlement since late December, a day after Federal Reserve Chairman Jerome Powell cast doubt about the prospect for a near-term rate reduction.
-

The Tell: More than 20% of institutional investors already own digital assets, Fidelity survey finds
As crypto enthusiasts fret over industry adoption of digital assets, results of a new survey suggests there’s little to worry about, with institutional investors showing no signs of throwing in the towel.
-

Tesla to raise money through new stock and convertible debt offerings
Tesla Inc. on Thursday filed for a capital raise, disclosing its intent to sell both common stock and convertible notes. Shares were up 5.6% in premarket trading.
-

Cannabis Watch: Why Aurora Cannabis hasn’t signed a deal with a U.S. giant like other pot companies
Aurora Cannabis Inc. is one of two major Canadian cannabis companies with a market value of more than $1.5 billion that has yet to ink a partnership or investment deal with a major U.S. company such as Constellation Brands Inc. deal with Canopy Growth Corp.
-

Strong banks and weak miners tug Europe markets in opposite directions
Outlook for commodities in focus as Citi downgrades BHP Group
-

These 6 biotech stocks are promising takeover targets
Cheap shares and fat product pipelines may lure big pharma to these appealing buyout candidates.